318 related articles for article (PubMed ID: 19289240)
1. The acute antipanic and anxiolytic activity of aerobic exercise in patients with panic disorder and healthy control subjects.
Ströhle A; Graetz B; Scheel M; Wittmann A; Feller C; Heinz A; Dimeo F
J Psychiatr Res; 2009 Aug; 43(12):1013-7. PubMed ID: 19289240
[TBL] [Abstract][Full Text] [Related]
2. Anxiety modulation by the heart? Aerobic exercise and atrial natriuretic peptide.
Ströhle A; Feller C; Strasburger CJ; Heinz A; Dimeo F
Psychoneuroendocrinology; 2006 Oct; 31(9):1127-30. PubMed ID: 17010527
[TBL] [Abstract][Full Text] [Related]
3. The acute antipanic activity of aerobic exercise.
Ströhle A; Feller C; Onken M; Godemann F; Heinz A; Dimeo F
Am J Psychiatry; 2005 Dec; 162(12):2376-8. PubMed ID: 16330604
[TBL] [Abstract][Full Text] [Related]
4. Megestrol attenuates the hormonal response to CCK-4-induced panic attacks.
Raedler TJ; Jahn H; Goedeken B; Gescher DM; Kellner M; Wiedemann K
Depress Anxiety; 2006; 23(3):139-44. PubMed ID: 16470820
[TBL] [Abstract][Full Text] [Related]
5. Effects of tiagabine on cholecystokinin-tetrapeptide (CCK-4)-induced anxiety in healthy volunteers.
Zwanzger P; Eser D; Padberg F; Baghai TC; Schule C; Rötzer F; Ella R; Möller HJ; Rupprecht R
Depress Anxiety; 2003; 18(3):140-3. PubMed ID: 14625878
[TBL] [Abstract][Full Text] [Related]
6. Acute exercise ameliorates reduced brain-derived neurotrophic factor in patients with panic disorder.
Ströhle A; Stoy M; Graetz B; Scheel M; Wittmann A; Gallinat J; Lang UE; Dimeo F; Hellweg R
Psychoneuroendocrinology; 2010 Apr; 35(3):364-8. PubMed ID: 19682803
[TBL] [Abstract][Full Text] [Related]
7. CCK-4-induced anxiety but not panic is associated with serum brain-derived neurotrophic factor in healthy subjects.
Maron E; Tõru I; Mäemets K; Sepp S; Vasar V; Shlik J; Zharkovsky A
J Psychopharmacol; 2009 Jun; 23(4):460-4. PubMed ID: 18562429
[TBL] [Abstract][Full Text] [Related]
8. Associations between personality traits and CCK-4-induced panic attacks in healthy volunteers.
Tõru I; Aluoja A; Võhma U; Raag M; Vasar V; Maron E; Shlik J
Psychiatry Res; 2010 Jul; 178(2):342-7. PubMed ID: 20471107
[TBL] [Abstract][Full Text] [Related]
9. One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI.
Schunck T; Mathis A; Erb G; Namer IJ; Hode Y; Demazières A; Luthringer R
J Psychopharmacol; 2011 Jan; 25(1):52-9. PubMed ID: 20498136
[TBL] [Abstract][Full Text] [Related]
10. The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteers.
Maron E; Tõru I; Vasar V; Shlik J
J Psychopharmacol; 2004 Jun; 18(2):194-9. PubMed ID: 15260907
[TBL] [Abstract][Full Text] [Related]
11. Acute exercise reduces the effects of a 35% CO2 challenge in patients with panic disorder.
Esquivel G; Díaz-Galvis J; Schruers K; Berlanga C; Lara-Muñoz C; Griez E
J Affect Disord; 2008 Apr; 107(1-3):217-20. PubMed ID: 17727960
[TBL] [Abstract][Full Text] [Related]
12. Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers.
Zwanzger P; Baghai TC; Schuele C; Ströhle A; Padberg F; Kathmann N; Schwarz M; Möller HJ; Rupprecht R
Neuropsychopharmacology; 2001 Nov; 25(5):699-703. PubMed ID: 11682253
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity to cholecystokinin-tetrapeptide in major depression.
Koszycki D; Copen J; Bradwejn J
J Affect Disord; 2004 Jun; 80(2-3):285-90. PubMed ID: 15207943
[TBL] [Abstract][Full Text] [Related]
14. Effect of CI-988 on cholecystokinin tetrapeptide-induced panic symptoms in healthy volunteers.
Bradwejn J; Koszycki D; Paradis M; Reece P; Hinton J; Sedman A
Biol Psychiatry; 1995 Dec; 38(11):742-6. PubMed ID: 8580227
[TBL] [Abstract][Full Text] [Related]
15. The relation between anger management style, mood and somatic symptoms in anxiety disorders and somatoform disorders.
Koh KB; Kim DK; Kim SY; Park JK; Han M
Psychiatry Res; 2008 Sep; 160(3):372-9. PubMed ID: 18718675
[TBL] [Abstract][Full Text] [Related]
16. Hypochondriacal concerns and somatization in panic disorder.
Furer P; Walker JR; Chartier MJ; Stein MB
Depress Anxiety; 1997; 6(2):78-85. PubMed ID: 9451549
[TBL] [Abstract][Full Text] [Related]
17. Effects of the GABA-reuptake inhibitor tiagabine on panic and anxiety in patients with panic disorder.
Zwanzger P; Eser D; Nothdurfter C; Baghai TC; Möller HJ; Padberg F; Rupprecht R
Pharmacopsychiatry; 2009 Nov; 42(6):266-9. PubMed ID: 19924586
[TBL] [Abstract][Full Text] [Related]
18. The effect of successful treatment on the emotional and physiological response to carbon dioxide inhalation in patients with panic disorder.
Gorman JM; Martinez J; Coplan JD; Kent J; Kleber M
Biol Psychiatry; 2004 Dec; 56(11):862-7. PubMed ID: 15576063
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin and panic disorder: past and future clinical research strategies.
Bradwejn J; Koszycki D
Scand J Clin Lab Invest Suppl; 2001; 234():19-27. PubMed ID: 11713976
[TBL] [Abstract][Full Text] [Related]
20. Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteers.
Maron E; Tõru I; Tasa G; Must A; Toover E; Lang A; Vasar V; Shlik J
Neurosci Lett; 2008 Dec; 446(2-3):88-92. PubMed ID: 18832011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
